Preoperative Serum FGF19 in the Prognosis of Biliary Atresia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorChildren's Hospital of Fudan University
About this trial
To investigate the role of preoperative serum FGF19 level in the prognosis of biliary atresia.
Eligibility criteria
Qualifiers
Samples diagnosed as biliary atresia in Children's Hospital of Fudan University
Samples with one-year follow-up records after surgery
Samples with a record of serum total bilirubin levels three months after surgery
Samples with preoperative serum left（volume > 500ul)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
200 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov